Leprosy Mailing List – September 2nd, 2010
Ref.: Clofazimine in recurrent type 2 (ENL) leprosy reaction.
From: B Naafs, Munnekeburen, The Netherlands
Dear Dr Ailton,
Thank you very much for your message dated LML Aug. 29th, 2007. I agree with the positive effect of lamprene (clofazimine) on recurrent ENL. It is still one of the drugs I use for this severe condition. Pieter Schreuder and I wrote a small letter to the editor about this:-
P.A.M. Schreuder and B. Naafs. Chronic recurrent ENL, steroid dependant: Long-term treatment with high dose of clofazimine. Lepr. Rev. 74 (2003) 386-389
This paper can be accessed via the Website of leprosy review. I have to admit that there is "no scientific evidence", but I believe you, and I have seen good results too.
The major argument against the success of lamprene is the time frame. Would it not have abated by its own?
The major argument against the success of lamprene is the time frame. Would it not have abated by its own?
I hope more colleagues will respond.
With kind regards,
Ben Naafs
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.